Steve E. Unger - Concepedia

Author

Steve E. Unger

Bristol-Myers Squibb (United States)

Also Known As

STEVE E. UNGER, STEVE UNGER, Steve E Unger, Steve E. Unger, Steve Unger

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Bristol-Myers Squibb (Germany)DuPont (United States)Research Triangle Park Foundation AstraZeneca (United Kingdom)

About

Steve E. Unger is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and drug analysis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	23	1K
2	Engineering	8	8	316
3	Natural Sciences	8	8	329
4	Arts	1	1	11
5	Health Sciences	1	1	35

Steve E. Unger

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Combined HPLC, NMR Spectroscopy, and Ion-Trap Mass Spectrometry with Application to the Detection and Characterization of Xenobiotic and Endogenous Metabolites in Human Urine John P. Shockcor, Steve E. Unger, Ian D. Wilson, Analytical Chemistry	1996	172
Direct Plasma Sample Injection in Multiple-Component LC−MS−MS Assays for High-Throughput Pharmacokinetic Screening Jing‐Tao Wu, Hang Zeng, Mingxin Qian, Analytical Chemistry ImmunologyPharmacodynamic ModelingPre-clinical PharmacologyGas ChromatographyBioanalysis	1999	149
Structure determination of lysobactin, a macrocyclic peptide lactone antibiotic Adrienne A. Tymiak, Terrence J. McCormick, Steve E. Unger The Journal of Organic Chemistry Bioorganic ChemistryAltmetric Attention ScorePeptide ScienceAntimicrobial ChemotherapyMedicinal Chemistry	1989	92
High‐speed gradient parallel liquid chromatography/tandem mass spectrometry with fully automated sample preparation for bioanalysis: 30 seconds per sample from plasma Yuzhong Deng, Jingtao Wu, Thomas L. Lloyd, Rapid Communications in Mass Spectrometry	2002	92
High‐speed liquid chromatography/tandem mass spectrometry using a monolithic column for high‐throughput bioanalysis Jing‐Tao Wu, Hang Zeng, Yuzhong Deng, Rapid Communications in Mass Spectrometry EngineeringBiological Mass SpectrometryHigh‐throughput BioanalysisBiomedical EngineeringMonolithic Columns	2001	90
Safety Assessment of Drug Metabolites: Characterization of Chemically Stable Metabolites W. Griffith Humphreys, Steve E. Unger Chemical Research in Toxicology Metabolomic ProfilingSecondary MetaboliteDrug MetabolitesNew DrugMedicinal Chemistry	2006	80
Quantitative determination of pioglitazone in human serum by direct-injection high-performance liquid chromatography mass spectrometry and its application to a bioequivalence study Yanyan Xue, K. C. Turner, J. Meeker, Journal of Chromatography B Bioequivalence StudyBiochemistryMedicineBioanalysisMass Spectrometry	2003	73
Novel direct detection method for quantitative determination of intracellular nucleoside triphosphates using weak anion exchange liquid chromatography/tandem mass spectrometry Guoen Shi, Jingtao Wu, Li Yu, Rapid Communications in Mass Spectrometry EngineeringIntracellular Nucleoside TriphosphatesNovel Analytical MethodImmunologyQuantitative Determination	2002	68
Neutral, seven-coordinate dioxime complexes of technetium(III): synthesis and characterization Karen E. Linder, Mary F. Malley, Jack Z. Gougoutas, Inorganic Chemistry Inorganic ChemistryChemical EngineeringEngineeringChemical AnalysisDonut Icon	1990	59
Application of directly coupled LC–NMR–MS to the structural elucidation of metabolites of the HIV-1 reverse-transcriptase inhibitor BW935U83 John P. Shockcor, Steve E. Unger, Paul Savina, Journal of Chromatography B Biomedical Sciences and Applications BiochemistryStructural ElucidationNatural SciencesHuman RetrovirusAntiviral Drug Development	2000	51

Page 1